X-153868561-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_001278116.2(L1CAM):c.1546G>A(p.Asp516Asn) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001278116.2 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- L1 syndromeInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- X-linked hydrocephalus with stenosis of the aqueduct of SylviusInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
- MASA syndromeInheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
- X-linked complicated corpus callosum dysgenesisInheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- X-linked complicated spastic paraplegia type 1Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| L1CAM | NM_001278116.2 | c.1546G>A | p.Asp516Asn | missense_variant, splice_region_variant | Exon 13 of 29 | ENST00000370060.7 | NP_001265045.1 | |
| L1CAM | NM_000425.5 | c.1546G>A | p.Asp516Asn | missense_variant, splice_region_variant | Exon 12 of 28 | NP_000416.1 | ||
| L1CAM | NM_024003.3 | c.1546G>A | p.Asp516Asn | missense_variant, splice_region_variant | Exon 12 of 27 | NP_076493.1 | ||
| L1CAM | NM_001143963.2 | c.1531G>A | p.Asp511Asn | missense_variant, splice_region_variant | Exon 11 of 26 | NP_001137435.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
Spastic paraplegia Uncertain:1
This sequence change replaces aspartic acid with asparagine at codon 516 of the L1CAM protein (p.Asp516Asn). The aspartic acid residue is weakly conserved and there is a small physicochemical difference between aspartic acid and asparagine. This variant also falls at the last nucleotide of exon 12 of the L1CAM coding sequence, which is part of the consensus splice site for this exon. This variant is not present in population databases (ExAC no frequency). This variant has been reported as hemizygous in individuals affected with L1 syndrome (PMID: 19846429). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at